Pharma Grade Cellulose Powder Market Valuation Expected To Reach $1.62 Billion By 2029, Growing At A Rate Of 6.2%
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Estimated Market Size of the Pharma Grade Cellulose Powder Market In 2029?
The market size for pharma-grade cellulose powder has observed robust growth in the past few years. Its size is forecasted to expand from $1.19 billion in 2024 to $1.27 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. The growth witnessed during the historic period may be due to factors such as the increased demand for tablet binders, a rise in the production of generic drugs, the escalation in pharmaceutical research and development, the growth in the manufacturing capacity of excipients, and regulatory endorsements for cellulose-based excipients.
The market for pharma-grade cellulose powder is forecasted to experience significant growth in the upcoming years, with a predicted market size of $1.62 billion in 2029 and a compound annual growth rate (CAGR) of 6.2%. The robust growth during the forecast period may be due to the increasing emphasis on personalized medicine, the use of sustainable excipients, growth in biologics and biosimilars, and augmented attention on revolutionary oral drug delivery systems, as well as significant investments in the pharmaceutical infrastructure in developing markets. The future trends anticipated during this period comprise an enhanced demand for excipient-grade materials for drug formulation, increased uptake in controlled-release drug delivery systems, a shift towards plant-based and renewable excipients, a rise in the implementation in controlled drug delivery systems, and progressive improvements in cellulose processing technologies to achieve better purity and efficiency.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp
Which Factors and External Forces Are Driving Demand in the Pharma Grade Cellulose Powder Market?
The growth of the pharma-grade cellulose powder market is anticipated to be driven by the burgeoning production of pharmaceutical goods. The creation of medications consists of formulating, synthesizing, and implementing stringent quality control on active ingredients and excipients, all to ensure that they are safe, efficient, and comply with all required regulations. The upsurge in chronic illnesses, which necessitate sustained and long-term treatment for effective control, is causing an increase in pharmaceutical production. Pharma-grade cellulose powder plays a crucial role in pharmaceutical production, serving as a reliable binder, filler, and stabilizer, thus preserving the integrity of tablets and facilitating equal drug dissemination. For example, the total pharmaceutical production in Europe, as reported by the Belgium-based European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents the European pharmaceutical industry, amounted to $422,803 million (€390,000 million) in June 2023, a rise from $393,857 million (€363,300 million) in 2022. Hence, the escalating pharmaceutical production is stimulating the pharma-grade cellulose powder market’s growth.
Which Segments in the Pharma Grade Cellulose Powder Offer the Most Growth?
The pharma grade cellulose powder market covered in this report is segmented –
1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)
2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent
3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications
4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries
Subsegments:
1) By Microcrystalline Cellulose: Powder, Granules
2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants
3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)
4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp
What Are the Fastest-Growing Geographies in the Pharma Grade Cellulose Powder Market?
North America was the largest region in the pharma-grade cellulose powder market in 2024. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive the Pharma Grade Cellulose Powder Market’s Growth?
Major firms in the pharma-grade cellulose powder industry are centered around establishing a new microcrystalline cellulose plant to extend their production potential and bolster their supply chain efficiency for pharmaceutical excipients. A microcrystalline cellulose site is a specific factory where refined cellulose is put through controlled chemical and mechanical procedures to produce uniform, premium-grade particles for medicinal usage. For instance, Nitika Pharmaceuticals Specialties, a reputed excipient manufacturing firm from India, marked the inception of Tabcell, India’s largest microcrystalline cellulose (MCC) production hub situated in Nagpur, in September 2023. With avant-garde technology and a capacity of 1200 metric tons, this plant was unveiled by Union Minister Nitin Gadkari, marking a significant achievement under the Production Linked Incentive (PLI) scheme for excipients by the Government of India. This new establishment reinforces Nitika Pharmaceutical’s status as a global front-runner in pharmaceutical excipients, catering to local demands as well as exporting to over 92 countries. It also supports the “Make in India” drive and significantly boosts local employment prospects.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report
What Are the Key Elements That Define the Pharma Grade Cellulose Powder Market?
Pharma grade cellulose powder is a refined, plant-based material designed to meet stringent pharmaceutical quality standards. It is commonly used as an excipient in drug formulations. Its chemically inert, non-toxic, and stable properties ensure compatibility with active pharmaceutical ingredients (APIs). It also enhances the uniformity and production efficiency of oral solid dosage forms.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/customise?id=24373&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model